|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 63.49 USD | +0.21% |
|
-2.98% | -16.42% |
| 11-03 | PTC Therapeutics Approves $500 Million Share Repurchase Program | MT |
| 11-03 | PTC Therapeutics, Inc. authorizes a Buyback Plan. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Other Pharmaceuticals | +0.21% | -2.98% | -16.42% | -15.68% | +63.47% | 5.3B |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















